These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 15789911

  • 21. [Clinical and morphologic comparisons in toxic goiter].
    Grigor'ev PIa, Samoteĭkin MA, Korolev RV.
    Arkh Patol; 1967; 29(6):55-8. PubMed ID: 4178179
    [No Abstract] [Full Text] [Related]

  • 22. Recovery from pancytopaenia and liver dysfunction after administration of propylthiouracil for Graves' disease.
    Kebapcilar L, Yeşil S, Bayraktar F, Saklamaz A, Demir T, Güngör O, Alacacioglu I, Cömlekçi A.
    N Z Med J; 2005 Aug 12; 118(1220):U1615. PubMed ID: 16132076
    [No Abstract] [Full Text] [Related]

  • 23. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM, Shawkat W.
    Nucl Med Commun; 2008 Jul 12; 29(7):642-8. PubMed ID: 18528187
    [Abstract] [Full Text] [Related]

  • 24. Thyroid orbitopathy.
    Fung S, Malhotra R, Selva D.
    Aust Fam Physician; 2003 Aug 12; 32(8):615-20. PubMed ID: 12973869
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of thyroid-associated ophthalmopathy: comparative study between prednisone and COP therapy].
    Min HY, Liu XP, Jiang RX, Lian L, Hu TS.
    Zhonghua Yan Ke Za Zhi; 2005 Sep 12; 41(9):781-5. PubMed ID: 16191342
    [Abstract] [Full Text] [Related]

  • 26. A treatment strategy for Graves' orbitopathy.
    Marcocci C, Pinchera A, Marinò M.
    Nat Clin Pract Endocrinol Metab; 2007 May 12; 3(5):430-6. PubMed ID: 17452970
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
    Eckstein AK, Lax H, Lösch C, Glowacka D, Plicht M, Mann K, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2007 Oct 12; 67(4):607-12. PubMed ID: 17880407
    [Abstract] [Full Text] [Related]

  • 29. [Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University].
    Kulig G, Kaźmierczyk-Puchalska A, Krzyzanowska-Swiniarska B, Pilarska K.
    Przegl Lek; 2004 Oct 12; 61(8):852-4. PubMed ID: 15789915
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines.
    Dasgupta S, Savage MW.
    Int J Clin Pract; 2005 Sep 12; 59(9):1097-100. PubMed ID: 16115188
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
    Eschmann SM, Thelen MH, Dittmann H, Bares R.
    Exp Clin Endocrinol Diabetes; 2006 May 12; 114(5):222-6. PubMed ID: 16804795
    [Abstract] [Full Text] [Related]

  • 34. The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy (TAO).
    Egle UT, Kahaly GJ, Petrak F, Hardt J, Batke J, Best J, Rothenbacher M.
    Exp Clin Endocrinol Diabetes; 1999 May 12; 107 Suppl 5():S168-71. PubMed ID: 10614914
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Graves' disease in childhood: advances in management with antithyroid drug therapy.
    Kaguelidou F, Carel JC, Léger J.
    Horm Res; 2009 May 12; 71(6):310-7. PubMed ID: 19506387
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The effect of one-month antithyroid therapy on peripheral metabolism of reactive oxygen species in Graves' disease with infiltrative ophthalmopathy].
    Bednarek J, Wysocki H, Sowiński J.
    Przegl Lek; 2004 May 12; 61(8):841-4. PubMed ID: 15789912
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.